Claudia M. König

  • Citations Per Year
Learn More
BACKGROUND Dalfampridine extended release 10mg tablets (D-ER) have demonstrated improvement in walking for ambulatory persons with multiple sclerosis (pwMS), termed "responders." OBJECTIVE This study examined the extent additional aspects of gait and dexterity change for patients prescribed D-ER. METHODS Over 14-weeks, walking endurance, dynamic gait,(More)
  • 1